IP Library Patent Application 18049343
Patent Application
App. No. 18/049,343

PRODUCTION OF RADIOISOTOPES WITH HIGHLY ENRICHED TARGET ENCLOSURE MATERIAL

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/049,343
Abstract

An enclosure for producing a radioisotope from an irradiation target material in a thimble guide tube of a nuclear reactor core is provided. The enclosure is comprised of an enriched material and defines a cavity therein. The cavity of the enclosure is configured to house the irradiation target material. A target assembly for producing synthetic radioisotopes and a method for producing pharmaceutical radioisotopes with a target assembly are also provided.

Claims (24)

1 . An enclosure for producing a radioisotope from an irradiation target material in a thimble guide tube of a nuclear reactor core, wherein the enclosure is comprised of an enriched material, wherein the enclosure defines a cavity therein, and wherein the cavity of the enclosure is configured to house the irradiation target material.

2 . The enclosure as claimed in claim 1 , wherein the enriched material has a short half-life upon being exposed to a neutron flux.

3 . The enclosure as claimed in claim 2 , wherein the enclosure has a short half-life upon exposure to a neutron flux.

4 . The enclosure as claimed in claim 1 , wherein the enriched material is isotopically pure.

5 . The enclosure as claimed in claim 4 , wherein the enriched material comprises a precursor to a beta emitter.

6 . The enclosure as claimed in claim 5 , wherein the enriched material comprises at least one of Nickel-64, Copper-63, or Copper-65.

7 . The enclosure as claimed in claim 1 , wherein the enriched material comprises an alloy.

8 . The enclosure as claimed in claim 1 , wherein the enclosure is comprised of a number of layers.

9 . The enclosure as claimed in claim 1 , wherein the enclosure comprises an outer wall comprised of the enriched material.

10 . A target assembly for producing synthetic radioisotopes, the target assembly comprising:

an enclosure defining a cavity therein, wherein the enclosure comprises an outer wall comprised of an enriched material; and

an irradiation target material positioned within the cavity of the enclosure, wherein the irradiation target material comprises a precursor to a first radioisotope.

11 . The target assembly as claimed in claim 10 , wherein the enriched material comprises a precursor to a second radioisotope, wherein the second radioisotope is a short lived radioisotope.

12 . The target assembly as claimed in claim 10 , wherein the enriched material comprises an isotopically pure metallic material.

13 . The target assembly as claimed in claim 12 , wherein the isotopically pure metallic material comprises at least one of Nickel-64, Copper-63, or Copper-65.

14 . The target assembly as claimed in claim 12 , wherein the enriched material comprises an alloy.

15 . The target assembly as claimed in claim 10 , wherein a layer of inert material is positioned between the enriched material and the cavity.

16 . A method for producing pharmaceutical radioisotopes with a target assembly, the method comprising:

inserting the target assembly into a thimble guide tube, the target assembly comprising an enclosure and at least one irradiation target material positioned within the enclosure, wherein the enclosure is comprised of an enriched material;

irradiating the target assembly with a neutron flux; and

removing the irradiated target assembly from the thimble guide tube to produce one or more pharmaceutical radioisotopes.

17 . The method as claimed in claim 16 , wherein the enriched material comprises Nickel-64, Copper-63, and/or Copper-65.

18 . The method as claimed in claim 16 , wherein the irradiation target material of the irradiated target assembly comprises Lutetium 177 and/or Actinium-225.

19 . The method as claimed in claim 16 , wherein each of the irradiation target material and the enclosure of the irradiated target assembly are comprised of a pharmaceutical radioisotope.

Assignments (2)
SECURITY INTEREST Recorded Jan 26, 2024
From: WESTINGHOUSE ELECTRIC COMPANY LLC; BHI ENERGY I SPECIALTY SERVICES LLC; STONE & WEBSTER, L.L.C. (FORMERLY STONE & WEBSTER, INC.)
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 066373/0604 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2023
From: CURRAN, CAROLINE E.; PRIBLE, MICHAEL C.; HEIBEL, MICHAEL D.
To: WESTINGHOUSE ELECTRIC COMPANY LLC
Reel/Frame 062383/0922 →